NCT06961643View on ClinicalTrials.gov

Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 5, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions

Diabetes Mellitus

Interventions

DRUG

HRS-7535 Tables

Oral HRS-7535 tables.

Trial Locations (1)

450015

RECRUITING

Henan Provincial Infectious Disease Hospital, Zhengzhou

All Listed Sponsors

lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06961643 - Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function | Biotech Hunter | Biotech Hunter